Serum BDNF levels and the antidepressant effects of electroconvulsive therapy with ketamine anaesthesia: a preliminary study
Objective To firstly examine the relationship between serum brain-derived neurotrophic factor (BDNF) levels and antidepressant response to ketamine as an anaesthesia in electroconvulsive therapy (ECT) in Chinese patients with treatment-refractory depression (TRD). Methods Thirty patients with TRD we...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
PeerJ Inc.
2021-02-01
|
Series: | PeerJ |
Subjects: | |
Online Access: | https://peerj.com/articles/10699.pdf |
_version_ | 1797418694121357312 |
---|---|
author | Wei Zheng Qiaomei Cen Sha Nie Minyi Li Rong Zeng Sumiao Zhou Dongbin Cai Miaoling Jiang Xiong Huang |
author_facet | Wei Zheng Qiaomei Cen Sha Nie Minyi Li Rong Zeng Sumiao Zhou Dongbin Cai Miaoling Jiang Xiong Huang |
author_sort | Wei Zheng |
collection | DOAJ |
description | Objective To firstly examine the relationship between serum brain-derived neurotrophic factor (BDNF) levels and antidepressant response to ketamine as an anaesthesia in electroconvulsive therapy (ECT) in Chinese patients with treatment-refractory depression (TRD). Methods Thirty patients with TRD were enrolled and underwent eight ECT sessions with ketamine anaesthesia (0.8 mg/kg) alone. Depression severity, response and remission were evaluated using the 17-item Hamilton Depression Rating Scale (HAMD-17). Enzyme-linked immunosorbent assay (ELISA) was applied to examine serum BDNF levels in patients with TRD at baseline and after the second, fourth and eighth ECT sessions. Baseline serum samples were also collected for 30 healthy controls. Results No significant differences were observed in serum BDNF levels between patients with TRD and healthy controls at baseline (p > 0.05). The remission rate was 76.7% (23/30) after the last ECT treatment, although all patients with TRD obtained antidepressant response criteria. Serum BDNF levels were not altered compared to baseline, even between remitters and nonremitters (all p > 0.05), despite the significant reduction in HAMD-17 and Brief Psychiatric Rating Scale (BPRS) scores after ECT with ketamine anaesthesia (all p < 0.05). The antidepressant effects of ECT with ketamine anaesthesia were not correlated with changes in serum BDNF levels (all p > 0.05). Conclusion This preliminary study indicated that serum BDNF levels do not appear to be a reliable biomarker to determine the antidepressant effects of ketamine as an anaesthesia in ECT for patients with TRD. Further studies with larger sample sizes are warranted to confirm these findings. |
first_indexed | 2024-03-09T06:36:39Z |
format | Article |
id | doaj.art-da131e3e1df64370a1696795672b4c21 |
institution | Directory Open Access Journal |
issn | 2167-8359 |
language | English |
last_indexed | 2024-03-09T06:36:39Z |
publishDate | 2021-02-01 |
publisher | PeerJ Inc. |
record_format | Article |
series | PeerJ |
spelling | doaj.art-da131e3e1df64370a1696795672b4c212023-12-03T10:57:29ZengPeerJ Inc.PeerJ2167-83592021-02-019e1069910.7717/peerj.10699Serum BDNF levels and the antidepressant effects of electroconvulsive therapy with ketamine anaesthesia: a preliminary studyWei Zheng0Qiaomei Cen1Sha Nie2Minyi Li3Rong Zeng4Sumiao Zhou5Dongbin Cai6Miaoling Jiang7Xiong Huang8The Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, ChinaThe Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, ChinaThe Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, ChinaThe Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, ChinaThe Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, ChinaThe Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, ChinaShenzhen Traditional Chinese Medicine Hospital, Shenzhen, ChinaThe Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, ChinaThe Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, ChinaObjective To firstly examine the relationship between serum brain-derived neurotrophic factor (BDNF) levels and antidepressant response to ketamine as an anaesthesia in electroconvulsive therapy (ECT) in Chinese patients with treatment-refractory depression (TRD). Methods Thirty patients with TRD were enrolled and underwent eight ECT sessions with ketamine anaesthesia (0.8 mg/kg) alone. Depression severity, response and remission were evaluated using the 17-item Hamilton Depression Rating Scale (HAMD-17). Enzyme-linked immunosorbent assay (ELISA) was applied to examine serum BDNF levels in patients with TRD at baseline and after the second, fourth and eighth ECT sessions. Baseline serum samples were also collected for 30 healthy controls. Results No significant differences were observed in serum BDNF levels between patients with TRD and healthy controls at baseline (p > 0.05). The remission rate was 76.7% (23/30) after the last ECT treatment, although all patients with TRD obtained antidepressant response criteria. Serum BDNF levels were not altered compared to baseline, even between remitters and nonremitters (all p > 0.05), despite the significant reduction in HAMD-17 and Brief Psychiatric Rating Scale (BPRS) scores after ECT with ketamine anaesthesia (all p < 0.05). The antidepressant effects of ECT with ketamine anaesthesia were not correlated with changes in serum BDNF levels (all p > 0.05). Conclusion This preliminary study indicated that serum BDNF levels do not appear to be a reliable biomarker to determine the antidepressant effects of ketamine as an anaesthesia in ECT for patients with TRD. Further studies with larger sample sizes are warranted to confirm these findings.https://peerj.com/articles/10699.pdfElectroconvulsive therapyKetamineDepressionBrain-derived neurotrophic factor |
spellingShingle | Wei Zheng Qiaomei Cen Sha Nie Minyi Li Rong Zeng Sumiao Zhou Dongbin Cai Miaoling Jiang Xiong Huang Serum BDNF levels and the antidepressant effects of electroconvulsive therapy with ketamine anaesthesia: a preliminary study PeerJ Electroconvulsive therapy Ketamine Depression Brain-derived neurotrophic factor |
title | Serum BDNF levels and the antidepressant effects of electroconvulsive therapy with ketamine anaesthesia: a preliminary study |
title_full | Serum BDNF levels and the antidepressant effects of electroconvulsive therapy with ketamine anaesthesia: a preliminary study |
title_fullStr | Serum BDNF levels and the antidepressant effects of electroconvulsive therapy with ketamine anaesthesia: a preliminary study |
title_full_unstemmed | Serum BDNF levels and the antidepressant effects of electroconvulsive therapy with ketamine anaesthesia: a preliminary study |
title_short | Serum BDNF levels and the antidepressant effects of electroconvulsive therapy with ketamine anaesthesia: a preliminary study |
title_sort | serum bdnf levels and the antidepressant effects of electroconvulsive therapy with ketamine anaesthesia a preliminary study |
topic | Electroconvulsive therapy Ketamine Depression Brain-derived neurotrophic factor |
url | https://peerj.com/articles/10699.pdf |
work_keys_str_mv | AT weizheng serumbdnflevelsandtheantidepressanteffectsofelectroconvulsivetherapywithketamineanaesthesiaapreliminarystudy AT qiaomeicen serumbdnflevelsandtheantidepressanteffectsofelectroconvulsivetherapywithketamineanaesthesiaapreliminarystudy AT shanie serumbdnflevelsandtheantidepressanteffectsofelectroconvulsivetherapywithketamineanaesthesiaapreliminarystudy AT minyili serumbdnflevelsandtheantidepressanteffectsofelectroconvulsivetherapywithketamineanaesthesiaapreliminarystudy AT rongzeng serumbdnflevelsandtheantidepressanteffectsofelectroconvulsivetherapywithketamineanaesthesiaapreliminarystudy AT sumiaozhou serumbdnflevelsandtheantidepressanteffectsofelectroconvulsivetherapywithketamineanaesthesiaapreliminarystudy AT dongbincai serumbdnflevelsandtheantidepressanteffectsofelectroconvulsivetherapywithketamineanaesthesiaapreliminarystudy AT miaolingjiang serumbdnflevelsandtheantidepressanteffectsofelectroconvulsivetherapywithketamineanaesthesiaapreliminarystudy AT xionghuang serumbdnflevelsandtheantidepressanteffectsofelectroconvulsivetherapywithketamineanaesthesiaapreliminarystudy |